SLC2A4 and type 2 diabetes mellitus: Since induction of GLUT4 translocation or expression has been proved to be effective for anti-T2DM therapy, the agents with dual functions in enhancing both GLUT4 translocation and expression are expected to exhibit more potent anti-diabetes properties.